Gallery

Diffusion Pharmaceuticals Announces Full Exercise of Underwriter’s Option to Purchase Additional Shares of Common Stock

Diffusion Pharmaceuticals Announces Full Exercise of Underwriter’s Option to Purchase Additional Shares of Common Stock 2560 1707 Diffusion Pharmaceuticals Inc.

CHARLOTTESVILLE, Va., February 18, 2021 — Diffusion Pharmaceuticals Inc.

Diffusion Pharmaceuticals Announces Closing of $30 Million Bought Deal Offering of Common Stock

Diffusion Pharmaceuticals Announces Closing of $30 Million Bought Deal Offering of Common Stock 2560 1707 Diffusion Pharmaceuticals Inc.

CHARLOTTESVILLE, Va., February 17, 2021 — Diffusion Pharmaceuticals Inc.

Diffusion Pharmaceuticals Completes Phase 1b Study of TSC in Hospitalized COVID-19 Patients

Diffusion Pharmaceuticals Completes Phase 1b Study of TSC in Hospitalized COVID-19 Patients 2560 1707 Diffusion Pharmaceuticals Inc.

CHARLOTTESVILLE, Va., Feb. 16, 2021 (GLOBE NEWSWIRE) — Diffusion Pharmaceuticals Inc.

Diffusion Pharmaceuticals to Participate in H.C. Wainwright BioConnect 2021 Conference

Diffusion Pharmaceuticals to Participate in H.C. Wainwright BioConnect 2021 Conference 2560 1707 Diffusion Pharmaceuticals Inc.

CHARLOTTESVILLE, Va., Jan. 11, 2021 (GLOBE NEWSWIRE)

Diffusion Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Business Updates

Diffusion Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Business Updates 2560 1707 Diffusion Pharmaceuticals Inc.

CHARLOTTESVILLE, Va., Nov. 12, 2020 (GLOBE NEWSWIRE)

Diffusion Pharmaceuticals Appoints Dr. Chris Galloway as Chief Medical Officer

Diffusion Pharmaceuticals Appoints Dr. Chris Galloway as Chief Medical Officer 2560 1707 Diffusion Pharmaceuticals Inc.

CHARLOTTESVILLE, Va. (October 19, 2020) – Diffusion Pharmaceuticals Inc.

Diffusion Pharmaceuticals Strengthens Management Team with Appointment of William Elder as General Counsel and Corporate Secretary

Diffusion Pharmaceuticals Strengthens Management Team with Appointment of William Elder as General Counsel and Corporate Secretary 2560 1707 Diffusion Pharmaceuticals Inc.

CHARLOTTESVILLE, Va., Sept. 24, 2020 (GLOBE NEWSWIRE)

Diffusion Pharmaceuticals to Present at the H.C. Wainwright 22nd Annual Virtual Global Investment Conference

Diffusion Pharmaceuticals to Present at the H.C. Wainwright 22nd Annual Virtual Global Investment Conference 2560 1707 Diffusion Pharmaceuticals Inc.

CHARLOTTESVILLE, Va., Sept. 11, 2020 (GLOBE NEWSWIRE)

Diffusion Pharmaceuticals Doses First Two Patients with TSC in COVID-19 Clinical Trial

Diffusion Pharmaceuticals Doses First Two Patients with TSC in COVID-19 Clinical Trial 2560 1707 Diffusion Pharmaceuticals Inc.

CHARLOTTESVILLE, Va., Sept. 10, 2020 (GLOBE NEWSWIRE)

Diffusion Pharmaceuticals Names Director Dr. Robert Cobuzzi as President and Chief Executive Officer

Diffusion Pharmaceuticals Names Director Dr. Robert Cobuzzi as President and Chief Executive Officer 2560 1707 Diffusion Pharmaceuticals Inc.

CHARLOTTESVILLE, Va., Sept. 08, 2020 (GLOBE NEWSWIRE)

  • 1
  • 2
Back to top